What is Perrigo Company's skin health — net sales?

Perrigo Company (PRGO) reported skin health — net sales of $151.9M in Q1 2026.

What does skin health — net sales mean?

This metric represents the total revenue generated from the sale of products within the company's Skin Health segment, which typically includes dermatological treatments, skincare solutions, and related therapeutic products. It serves as a key indicator of the company's market penetration and consumer demand within the specialized skin health category. Tracking this figure allows investors to assess the growth trajectory and competitive performance of the company's dermatological portfolio relative to broader consumer health trends.

Perrigo Company PRGO Skin Health — Net Sales

Other product segments

Oral Care

$354.4M-5.4%

Upper Respiratory

$197.4M-8.1%

Healthy Lifestyle

$142.7M-9.1%

Pain & Sleep

$106.6M—

Digestive Health

$96.6M-14.4%

Women's Health

$55.1M+11.3%

Similar metrics at other companies

KVUESkin Health and Beauty — Net Sales

$1.06B+8.4%

IFFHealth & Biosciences — Net Sales

$595M+10.2%

CLXHealth and Wellness — Net Sales

$629M-0.2%

PGHealth Care — Net Sales

$3.07B+6.7%

BCPCHuman Nutrition and Health — Net Sales

$171.63M+8.3%

PGBeauty — Net Sales

$3.87B+10.8%

Other financials

Income statement

See full

Revenue$969.2M-7.2%

Gross profit$325.5M-17.0%

Operating income-$372.3M-894%

Net income-$398.6M-6,128%

EPS (diluted)-$2.87-5,640%

Balance sheet

See full

Cash & equivalents$357.2M-12.9%

Total debt$3.8B-0.6%

Total equity$2.5B-42.7%

Total assets$8.0B-18.2%

Cash flow

See full

Operating cash flow-$113.6M-76.1%

CapEx$13.8M-45.9%

Free cash flow-$127.4M-41.6%

Valuation

See full

Market cap$1.35B-62.9%

Enterprise value$4.82B-32.0%

P/S0.3×-0.5×

Profitability

See full

Gross margin34.2%-2.2pp

Operating margin-36.9%-41.8pp

Net margin-43.5%-48.6pp

FCF margin4.2%-2.0pp

Returns & leverage

See full

Return on equity-53%-57.7pp

Debt / equity1.5×+0.6×

Current ratio2.7×+0.4×

Where this comes from

Reported directly by Perrigo Company in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Perrigo Company’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perrigo Company's skin health — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Perrigo Company's skin health — net sales?: Perrigo Company (PRGO) reported skin health — net sales of $151.9M in Q1 2026.
What does skin health — net sales mean?: This metric represents the total revenue generated from the sale of products within the company's Skin Health segment, which typically includes dermatological treatments, skincare solutions, and related therapeutic products. It serves as a key indicator of the company's market penetration and consumer demand within the specialized skin health category. Tracking this figure allows investors to assess the growth trajectory and competitive performance of the company's dermatological portfolio relative to broader consumer health trends.